ADVANCE EXT · 105MS302
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, blinded-dose-frequency extension study evaluating the long-term safety and efficacy of pegylated interferon beta-1a (BIIB017) in participants with relapsing multiple sclerosis. EudraCT: 2010-024477-39.
Sponsor: BIOGEN
Phase: III
Area: Neuroimmunology